120 related articles for article (PubMed ID: 27592511)
1. Cancer pain relief achieved by disrupting tumor-driven semaphorin 3A signaling in mice.
Maeda T; Yamada D; Kawahara K
Neurosci Lett; 2016 Oct; 632():147-51. PubMed ID: 27592511
[TBL] [Abstract][Full Text] [Related]
2. Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer.
Yamada D; Takahashi K; Kawahara K; Maeda T
Biochem Biophys Res Commun; 2016 Nov; 480(3):375-379. PubMed ID: 27769863
[TBL] [Abstract][Full Text] [Related]
3. Plexin A1 signaling confers malignant phenotypes in lung cancer cells.
Yamada D; Watanabe S; Kawahara K; Maeda T
Biochem Biophys Res Commun; 2016 Nov; 480(1):75-80. PubMed ID: 27717823
[TBL] [Abstract][Full Text] [Related]
4. mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling.
Yamada D; Kawahara K; Maeda T
Biochem Biophys Res Commun; 2016 Aug; 476(4):475-480. PubMed ID: 27246732
[TBL] [Abstract][Full Text] [Related]
5. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
[TBL] [Abstract][Full Text] [Related]
6. Spinal SET7/9 may contribute to the maintenance of cancer-induced bone pain in mice.
Hang LH; Xu ZK; Wei SY; Shu WW; Luo H; Chen J
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1001-1007. PubMed ID: 28557056
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A.
de Ridder D; Marino S; Bishop RT; Renema N; Chenu C; Heymann D; Idris AI
Sci Rep; 2018 May; 8(1):6877. PubMed ID: 29720701
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin-3A inhibits multiple myeloma progression in a mouse model.
Lavi N; Kessler O; Ziv K; Nir-Zvi I; Mumblat Y; Eiza N; Paran Y; Brenner B; Vadasz Z; Neufeld G
Carcinogenesis; 2018 Oct; 39(10):1283-1291. PubMed ID: 30102336
[TBL] [Abstract][Full Text] [Related]
9. Inoculation of Lewis lung carcinoma cells enhances formalin-induced pain behavior and spinal Fos expression in mice.
Choi JG; Kim JM; Kang DW; Choi JW; Park JB; Ahn SH; Ryu Y; Kim HW
J Vet Sci; 2017 Sep; 18(3):267-272. PubMed ID: 27586465
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell-derived semaphorin 3A inhibits filopodia formation by blood vascular tip cells.
Ochsenbein AM; Karaman S; Proulx ST; Berchtold M; Jurisic G; Stoeckli ET; Detmar M
Development; 2016 Feb; 143(4):589-94. PubMed ID: 26884395
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the semaphorin 3A pathway in prostatic cancer.
Yacoub M; Coulon A; Celhay O; Irani J; Cussenot O; Fromont G
Histopathology; 2009 Oct; 55(4):392-8. PubMed ID: 19817889
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of semaphorin 3A in osteoclasts causes lymphatic expansion in a Gorham-Stout disease (GSD) mouse model.
Zhang D; Xu H; Qin C; Cai K; Zhang J; Xia X; Bi J; Zhang L; Xing L; Liang Q; Wang W
J Zhejiang Univ Sci B; 2024 Jan; 25(1):38-50. PubMed ID: 38163665
[TBL] [Abstract][Full Text] [Related]
14. Effects of semaphorin 3A on retinal pigment epithelial cell activity.
Bai Y; Yu W; Han N; Yang F; Sun Y; Zhang L; Zhao M; Huang L; Zhou A; Wang F; Li X
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6628-38. PubMed ID: 24045994
[TBL] [Abstract][Full Text] [Related]
15. Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain.
Jiang J; Zhang J; Yao P; Wu X; Li K
Int J Oncol; 2014 Jul; 45(1):235-44. PubMed ID: 24818668
[TBL] [Abstract][Full Text] [Related]
16. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
[TBL] [Abstract][Full Text] [Related]
17. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
Catalano A
J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell-derived secretory factor downregulates Semaphorin-3a in osteoblasts by activating mammalian target of rapamycin pathway.
Yamada D; Kawahara K; Ozaki M; Maeda T
Biosci Biotechnol Biochem; 2016 May; 80(5):942-4. PubMed ID: 26865270
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Spinal CCR5/PKCγ Signaling Pathway in the Maintenance of Cancer-Induced Bone Pain.
Hang LH; Li SN; Dan X; Shu WW; Luo H; Shao DH
Neurochem Res; 2017 Feb; 42(2):563-571. PubMed ID: 27848062
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 3A controls timing and patterning of the dental pulp innervation.
Moe K; Sijaona A; Shrestha A; Kettunen P; Taniguchi M; Luukko K
Differentiation; 2012 Dec; 84(5):371-9. PubMed ID: 23142733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
